Imiglucerase
Cerezyme (imiglucerase) is an enzyme pharmaceutical. Imiglucerase was first approved as Cerezyme on 1994-05-23. It is used to treat gaucher disease, liver diseases, and splenic diseases in the USA. It has been approved in Europe to treat gaucher disease.
| Trade Name | Cerezyme |
|---|---|
| Common Name | Imiglucerase |
| Indication | gaucher disease, liver diseases, splenic diseases |
| Drug Class | Enzymes |
